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  Fifty mi｝ligrams of chlormadinone acetate （CMA） was daily administered to 20 cases of benign
prostatic hypertrophy for 4 to 26 weeks．
  As results， retardation， protraction， hesitancy in initiating the urinary stream， loss of force and
decrease of cariber of the stream and rate of residual urine could be improved in considerable degree．
As te side effects， impotence could be detected in 3 among 20 cases， but it was recovered by withdrawal
of the administration．
  CMA seems to be usefu1 for conservative treatment of benign prostatic hypertrophy．
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Tabte 2． Comparison of voiding condition
     before and after administration
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Fig． 2． Change at a rate of residual urine
    through before and after adminis－




































































6） Geller J et al： JAMA 2iO： 1421一・一1427， 1969
             （1981年4月27日受付）
